FIELD: medicine.
SUBSTANCE: proliferation inducing ligand (APRIL), and apoptosis inducing ligand (TRAIL) are measured in menstrual discharge by immunoenzyme technique; if APRIL ranges from 4.8 to 6.4 ng/ml, whereas TRAIL is from 24.0 to 27.0 pg/ml, simple hysteromyoma is diagnosed, and if APRIL falls within the range from 11.1 to 14.7 ng/ml, and TRAIL is between 20.0 to 22.5 pg/ml, fast-growing hysteromyoma is diagnosed.
EFFECT: more accurate differential diagnosis of simple and fast-growing hysteromyoma with a normal endometrial patterns, enabled measurement of a rate of hysteromyoma growth, effective hormone therapy, optimised individual management plan.
1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR RAPID HYSTEROMYOMA DEVELOPMENT PREDICTION | 2016 |
|
RU2626676C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR SIMPLE AND FAST-GROWING HYSTEROMYOMA WITH NORMAL ENDOMETRIAL STRUCTURE | 2013 |
|
RU2554824C1 |
| DIAGNOSTIC TECHNIQUE IN COMPLEX ENDOMETRIAL HYPERPLASIA WITHOUT ATYPIA | 2011 |
|
RU2459211C1 |
| METHOD FOR DIAGNOSING PROLIFERATIVE ACTIVITY OF UTERINE LEIOMYOMA CELLS | 2019 |
|
RU2700003C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF LEIOMYOMA GROWTH PATTERNS | 2013 |
|
RU2542468C1 |
| METHOD FOR PREDICTING UTERINE LEIOMYOMA SIZE INCREASE | 2019 |
|
RU2704819C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR UTERUS LEIOMYOMA GROWTH TYPE | 2008 |
|
RU2361216C1 |
| METHOD FOR PREDICTING THE PROBABILITY OF DEVELOPMENT OF PROLIFERATING UTERUS MYOMA | 2018 |
|
RU2676035C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSTICS OF QUICKLY METASTASING UTERINE LEIOMYOMA | 2003 |
|
RU2258222C2 |
| METHOD OF TREATING BENIGN HYPERPLASTIC ENDOMETRIAL PROCESSES IN PATIENTS WITH METABOLIC SYNDROME | 2010 |
|
RU2438662C1 |
